microRNA-124: a putative therapeutic target and biomarker for major depression.
about
Macrophage Migration Inhibitory Factor and microRNA-451a in Response to Mindfulness-Based Therapy or Treatment as usual in Patients with Depression, Anxiety or Stress- and Adjustment Disorders.The role of microRNAs in glucocorticoid action.Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response.MicroRNAs in depression and suicide: Recent insights and future perspectives
P2860
microRNA-124: a putative therapeutic target and biomarker for major depression.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
microRNA-124: a putative therapeutic target and biomarker for major depression.
@en
microRNA-124: a putative therapeutic target and biomarker for major depression.
@nl
type
label
microRNA-124: a putative therapeutic target and biomarker for major depression.
@en
microRNA-124: a putative therapeutic target and biomarker for major depression.
@nl
prefLabel
microRNA-124: a putative therapeutic target and biomarker for major depression.
@en
microRNA-124: a putative therapeutic target and biomarker for major depression.
@nl
P2860
P1476
microRNA-124: a putative therapeutic target and biomarker for major depression
@en
P2093
Yogesh Dwivedi
P2860
P304
P356
10.1080/14728222.2017.1328501
P407
P577
2017-05-25T00:00:00Z